Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Jasper Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for JSPR.
You can purchase shares of Jasper Therapeutics (NASDAQ:JSPR) through any online brokerage.
Other companies in Jasper Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Inozyme Pharma (NASDAQ:INZY), Inovio Pharmaceuticals (NASDAQ:INO), Adaptimmune Therapeutics (NASDAQ:ADAP) and Vistagen Therapeutics (NASDAQ:VTGN).
Jasper Therapeutics has a consensus price target of $49.82.
The stock price for Jasper Therapeutics (NASDAQ: JSPR) is $4.56 last updated April 23, 2025 at 4:00 PM EDT.
There are no upcoming dividends for Jasper Therapeutics.
Jasper Therapeutics’s Q1 earnings are confirmed for Tuesday, May 13, 2025.
There is no upcoming split for Jasper Therapeutics.
Jasper Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.